The Final Evaluation of the Opportunities for Mother and Infants Development Project

Publication Date: 04/08/2021

The Opportunities for Mother and Infant Development (OMID) is a three year project (from 2018 to 2021), funded by The Glaxo Smith Kline (GSK). The current phase of the project has been implemented in the two districts (16th and 17th) in Kabul city. The main purpose of the project is to improve the health and reduce the mortality among mothers, newborns and children in the most vulnerable communities through community-based interventions facilitated and delivered by Community Health Workers (CHWs) and Community Midwives (CMWs).

Overall, the project has been effective in achieving the intended outcomes. Access and utilization of Maternal and Neonatal Child Health (MNCH) services have improved as demonstrated by achievement of the project’s key performance indicators across the continuum of care.

This included increases in the %:
- of women reporting ANC utilization
- of women who undertook the first ANC visit before by the 3rd trimester of their pregnancy
- of those who knew the date that the baby was expected to arrive
- of those women who had a plan where she would deliver the baby
- of those women who believed health facility is safer to deliver there

And decreases in the %:
- of those who didn’t go for ANC and believed it is not important
- of those who didn’t go for ANC and indicated the high cost of care as reason

The community systems strengthening undertaken by the project through establishment of community based health facilities and CHWs was effective in increasing health awareness and adoption of positive MNCH behaviors and practices.

Language
Countries
Evaluation Type